指南与共识泌尿生殖与妇科肿瘤放疗放疗物理与技术

宫颈癌腹主动脉旁淋巴结区勾画图谱:设计与验证

An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
指南 / 共识 · Radiother Oncol · 2018-03-06

本研究基于21例宫颈癌患者39枚PET-CT识别的腹主动脉旁淋巴结设计CT勾画图谱,并在10例患者29枚淋巴结中验证。推荐的临床靶区为主动脉周围10mm、侧方15mm,下腔静脉前内侧8mm、后外侧6mm,设计队列覆盖97%(38/39),验证队列覆盖97%(28/29)。

要点

  • 推荐腹主动脉旁淋巴结CTV:主动脉环周10mm、侧方15mm;下腔静脉前内侧8mm、后外侧6mm。
  • 该CTV在设计队列覆盖97%(38/39)腹主动脉旁淋巴结。
  • 前瞻性验证队列中该CTV覆盖97%(28/29)腹主动脉旁淋巴结。

核心结论

  • 研究提出宫颈癌腹主动脉旁淋巴结CTV勾画范围:主动脉环周10mm、侧方15mm,下腔静脉前内侧8mm、后外侧6mm,验证队列覆盖97%(28/29)淋巴结。

研究设计与样本

  • 前瞻性研究,设计队列纳入21例宫颈癌患者,PET-CT识别39枚腹主动脉旁淋巴结。
  • 验证队列纳入10例患者,PET-CT识别29枚腹主动脉旁淋巴结。
  • 基于CT模拟扫描勾画淋巴结并测量其中心至主动脉和下腔静脉边缘距离,非对称外扩建立CTV。

主要发现

  • 设计队列中淋巴结中心至主动脉平均距离8mm(范围4-17),LLPA和AC区范围分别为4-17和4-15。
  • 设计队列中下腔静脉至淋巴结中心平均距离RPC区5mm(范围4-6)、AC区6mm(范围3-15)。
  • 无腹主动脉旁淋巴结位于T12-L1椎间隙或左肾静脉以上,或L5-S1椎间隙以下。
  • 验证队列中淋巴结中心至主动脉平均距离LLPA区9mm(范围5-15)、AC区7mm(范围6.5-14)。
  • 验证队列中下腔静脉至淋巴结中心平均距离RPC区3mm(范围2.5-4)、AC区5mm(范围3-10)。

关键数值与推荐

  • 推荐CTV:主动脉环周10mm、侧方15mm,下腔静脉前内侧8mm、后外侧6mm。
  • 该CTV在设计队列覆盖97%(38/39)腹主动脉旁淋巴结,验证队列覆盖97%(28/29)。

临床怎么用

  • 可依据所附详细勾画指南和视觉图谱,在宫颈癌患者中勾画腹主动脉旁淋巴结CTV。
  • 勾画范围上界不超过T12-L1椎间隙或左肾静脉,下界不低于L5-S1椎间隙。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Previous studies have investigated the anatomical distribution of para-aortic lymph nodes (PAN) in patients with cervical cancer. However, an atlas for accurate clinical target volume (CTV) delineation has yet to be defined. The purpose of this study was to design and verify a computerized tomography (CT) atlas to provide guidance for contouring the PAN CTV in patients with cervical cancer. MATERIALS AND METHODS: This prospective study included 21 cervical cancer patients (design cohort) with 39 pathological PAN identified on (18)F-FDG PET-CT. PAN [left lateral para-aortic (LLPA), aorto-caval (AC), right para-caval (RPC) nodes] were delineated on CT simulation scans. Measurements were taken from the volumetric centre of the nodes to the edge of aorta and inferior vena-cava (IVC). Initially the aorta and IVC were expanded by the mean distance to the lymph node centre to create a CTV. Expansion margins were then increased asymmetrically until the CTV resulted in a clinically acceptable number of PAN included. The CTV was validated on a further 10 patients (validation cohort) with 29 PAN. A detailed contouring guide and accompanying visual atlas for elective PAN CTV delineation was created based on the validated margins. RESULTS: For the design cohort (n = 21 patients, 39 PAN), the mean distance from the centre of the node to the aorta was 8 mm (range 4-17) for both LLPA (range 4-17) and AC (range 4-15) regions. Mean distance from the IVC to the centre of the nodes was 5 mm (range 4-6) in the RPC region and 6 mm (range 3-15) in the AC region. No PAN was superior to the T12-L1 interspace or the left renal vein or inferior to the L5-S1 interspace. For validation cohort (n = 10 patients, 29 PAN), mean distance from centre of the node to the aorta was 9 mm (range 5-15) in the LLPA region, 7 mm (range 6.5-14) in the AC region. Mean distance from the ICV to the centre of the nodes was 3 mm (range 2.5-4) in the RPC region and 5 mm (range 3-10) in the AC region. A CTV expansion from the aorta of 10 mm circumferentially and 15 mm laterally, and from the IVC of 8 mm anteromedially and 6 mm posterolaterally resulted in coverage of 97% (38/39) of PAN in the design cohort. On prospective validation, the described CTV included 97% (28/29) of PAN in the validation cohort. CONCLUSION: We propose the following PAN CTV; expansion from aorta of 10 mm circumferentially except 15 mm laterally, expansion from the IVC of 8 mm anteromedial and 6 mm posterolaterally. The suggested CTV includes 97% (28/29) PAN in a validated patient cohort. A detailed guide and accompanying visual atlas is provided to aid delineation of the PAN CTV in patients with cervical cancer.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Keenan LG, Rock K, Azmi A, et al. An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines. Radiother Oncol. 2018. PMID: 29523410. doi:10.1016/j.radonc.2018.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。